Back to School: How biopharma can reboot drug development. Access exclusive analysis here

GenVec, Vical report HIV vaccine data

GNVC and VICL said pooled data from three Phase IIa studies of a vaccine to prevent HIV, collectively

Read the full 183 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE